Based on TCGA database, we found that NSCLC exhibited higher KRT19 expression than control group (Fig. 2B-C), and p21 levels were notably lower in NSCLC tissues compared with normal control (Figure S8). The gene discussed is KRT19; the disease is non-small cell lung carcinoma.